"Pulse Therapy, Drug" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Administration of high doses of pharmaceuticals over short periods of time.
Concept/Terms
Pulse Therapy, Drug- Pulse Therapy, Drug
- Drug Pulse Therapies
- Pulse Therapies, Drug
- Therapies, Drug Pulse
- Therapy, Drug Pulse
- Pulse Drug Therapy
- Drug Therapies, Pulse
- Drug Therapy, Pulse
- Pulse Drug Therapies
- Therapies, Pulse Drug
- Therapy, Pulse Drug
- Drug Pulse Therapy
Below are MeSH descriptors whose meaning is more general than "Pulse Therapy, Drug".
Below are MeSH descriptors whose meaning is more specific than "Pulse Therapy, Drug".
This graph shows the total number of publications written about "Pulse Therapy, Drug" by people in Harvard Catalyst Profiles by year, and whether "Pulse Therapy, Drug" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 0 | 1 | 1 |
2001 | 0 | 2 | 2 |
2002 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2007 | 0 | 2 | 2 |
2009 | 0 | 2 | 2 |
2011 | 0 | 3 | 3 |
2012 | 0 | 2 | 2 |
2013 | 0 | 2 | 2 |
2014 | 0 | 1 | 1 |
2015 | 0 | 2 | 2 |
2017 | 1 | 1 | 2 |
2020 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
Below are the most recent publications written about "Pulse Therapy, Drug" by people in Profiles.
-
Effect of Early High-Dose Vitamin D3 Repletion on Cognitive Outcomes in Critically Ill Adults. Chest. 2021 09; 160(3):909-918.
-
Fulminant myocarditis triggered by OC43 subtype coronavirus: a disease deserving evidence-based care bundles. J Cardiovasc Med (Hagerstown). 2020 07; 21(7):529-531.
-
Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis. Intern Med. 2018 Dec 01; 57(23):3473-3478.
-
Pulse Dose Erlotinib and Zuckerguss Improvement in EGFR-Mutant NSCLC. J Thorac Oncol. 2017 12; 12(12):1857-1858.
-
Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers. Ann Oncol. 2017 02 01; 28(2):278-284.
-
Non-granulomatous myositis in a patient with ulcerative colitis who showed symptoms resembling gastrocnemius myalgia syndrome. Rinsho Shinkeigaku. 2017 02 25; 57(2):71-76.
-
Medical mirroring: granulomatosis with polyangiitis (formerly Wegener's) mimicking immunoglobulin-G4 related disease. Int J Rheum Dis. 2018 Apr; 21(4):885-889.
-
Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival. J Interv Card Electrophysiol. 2015 Mar; 42(2):117-24.
-
If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation. Heart Rhythm. 2014 Dec; 11(12):2288-96.
-
Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2013 Nov; 98(11):E1790-5.